Skip to content

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis

Association of Microplastic Exposure With Pathological Stages of Gastric Mucosal Carcinogenesis: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07542652
Enrollment
450
Registered
2026-04-21
Start date
2026-03-31
Completion date
2026-12-31
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Carcinoma, Gastric Precancerous Lesions, Gastritis Chronic, Intestinal Metaplasia

Brief summary

The objective of this clinical trial is to explore the correlation between the level of microplastic exposure and the risk of gastric mucosal carcinogenesis, and to evaluate the strength of its effect as an independent risk factor. The main questions it aims to answer include: Does the level of microplastic exposure increase the risk of gastric mucosal carcinogenesis? Can the correlation between the level of microplastic exposure and gastric mucosal carcinogenesis, as well as the sources of high - risk microplastic exposure, be explored through a questionnaire on external microplastic exposure? Researchers will complete a design structured questionnaire and ask participants to fill it out carefully and truthfully to determine whether the level of microplastic exposure increases the risk of gastric mucosal carcinogenesis.

Detailed description

The study will categorize participants into three groups based on endoscopic and/or histopathological findings: chronic non-atrophic gastritis, precancerous lesions, and gastric cancer. Basic demographic information, \*Helicobacter pylori\* infection status, and plastic exposure assessment scores will be recorded for each group.

Interventions

None listed

Sponsors

Yongquan Shi
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 75 years old, gender is not restricted * Having a clear diagnosis result within the recent three months and being diagnosed with chronic non - atrophic gastritis, precancerous lesions of gastric cancer, or gastric cancer for the first time * Have clear Helicobacter pylori (Hp) test results * Be in normal mental state and able to independently complete the questionnaire survey

Exclusion criteria

* Patients with a history of malignant tumors in other parts * Patients who have previously undergone upper gastrointestinal surgery, chemotherapy, or radiotherapy * Patients with severe diseases of major organs such as the heart, lungs liver, and kidneys * Patients who are currently receiving psychological intervention or taking psychiatric drugs * Pregnant or lactating women * Patients with severe missing clinical data or questionnaire information * Refusing to sign the informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Correlation between external exposure levels of microplastics and three pathological stages of gastric mucosal carcinogenesis9 monthsThe investigators evaluated the correlation between external exposure to microplastics and the three pathological stages of gastric mucosal carcinogenesis based on the patients' final diagnosis results and the completed questionnaires they filled out.

Secondary

MeasureTime frameDescription
Analysis of sources of high - risk microplastic exposure9 monthsAnalyze the sources of high-risk microplastic exposure by comparing the scores of each item in the questionnaires of the three groups of participants.
Synergistic toxicity of microplastics and Helicobacter pylori9 monthsAnalyze whether microplastics synergistically promote gastric mucosal injury and increase the risk of canceration with Helicobacter pylori through interaction.

Countries

China

Contacts

CONTACTYongquan Shi
shiyquan@fmmu.edu.cn029-84771515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026